Cargando…

Propofol-Related Infusion Syndrome in the Peripartum Period

Background Propofol is a widely known, commonly used drug. Complications can occur with the use of this drug, including propofol-related infusion syndrome (PRIS). PRIS, in the obstetric population, has not been documented; however, we report a case of a patient who developed PRIS after an emergent c...

Descripción completa

Detalles Bibliográficos
Autores principales: Eziefule, Akwugo A., Elshatanoufy, Solafa, Thakur, Mili, Rocha, Frederico G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061574/
https://www.ncbi.nlm.nih.gov/pubmed/27738550
http://dx.doi.org/10.1055/s-0036-1593405
_version_ 1782459622871793664
author Eziefule, Akwugo A.
Elshatanoufy, Solafa
Thakur, Mili
Rocha, Frederico G.
author_facet Eziefule, Akwugo A.
Elshatanoufy, Solafa
Thakur, Mili
Rocha, Frederico G.
author_sort Eziefule, Akwugo A.
collection PubMed
description Background Propofol is a widely known, commonly used drug. Complications can occur with the use of this drug, including propofol-related infusion syndrome (PRIS). PRIS, in the obstetric population, has not been documented; however, we report a case of a patient who developed PRIS after an emergent cesarean delivery of a preterm infant. Case Study A 35-year-old multigravida woman presented complaining of leakage of fluid and decreased fetal movement. Her pregnancy was complicated by methadone maintenance therapy due to a history of opioid abuse. Complications after admission for prolonged monitoring and a prolonged fetal heart tone deceleration was noted with no recovery despite intrauterine resuscitation. An emergent cesarean delivery was performed using general anesthesia and endotracheal intubation after which she developed aspiration pneumonia. She was admitted to the intensive care unit and reintubation and sedation were required secondary to respiratory distress. Sedation was achieved using propofol infusion. She subsequently developed changes in her electrocardiogram, an increase of her serum creatinine, creatinine protein kinase, lipase, amylase, and triglycerides, making the diagnosis of PRIS. Conclusion PRIS should be included in the differential diagnosis of intubated or postoperative patients in the obstetric population.
format Online
Article
Text
id pubmed-5061574
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Thieme Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-50615742016-10-13 Propofol-Related Infusion Syndrome in the Peripartum Period Eziefule, Akwugo A. Elshatanoufy, Solafa Thakur, Mili Rocha, Frederico G. AJP Rep Background Propofol is a widely known, commonly used drug. Complications can occur with the use of this drug, including propofol-related infusion syndrome (PRIS). PRIS, in the obstetric population, has not been documented; however, we report a case of a patient who developed PRIS after an emergent cesarean delivery of a preterm infant. Case Study A 35-year-old multigravida woman presented complaining of leakage of fluid and decreased fetal movement. Her pregnancy was complicated by methadone maintenance therapy due to a history of opioid abuse. Complications after admission for prolonged monitoring and a prolonged fetal heart tone deceleration was noted with no recovery despite intrauterine resuscitation. An emergent cesarean delivery was performed using general anesthesia and endotracheal intubation after which she developed aspiration pneumonia. She was admitted to the intensive care unit and reintubation and sedation were required secondary to respiratory distress. Sedation was achieved using propofol infusion. She subsequently developed changes in her electrocardiogram, an increase of her serum creatinine, creatinine protein kinase, lipase, amylase, and triglycerides, making the diagnosis of PRIS. Conclusion PRIS should be included in the differential diagnosis of intubated or postoperative patients in the obstetric population. Thieme Medical Publishers 2016-10 /pmc/articles/PMC5061574/ /pubmed/27738550 http://dx.doi.org/10.1055/s-0036-1593405 Text en © Thieme Medical Publishers
spellingShingle Eziefule, Akwugo A.
Elshatanoufy, Solafa
Thakur, Mili
Rocha, Frederico G.
Propofol-Related Infusion Syndrome in the Peripartum Period
title Propofol-Related Infusion Syndrome in the Peripartum Period
title_full Propofol-Related Infusion Syndrome in the Peripartum Period
title_fullStr Propofol-Related Infusion Syndrome in the Peripartum Period
title_full_unstemmed Propofol-Related Infusion Syndrome in the Peripartum Period
title_short Propofol-Related Infusion Syndrome in the Peripartum Period
title_sort propofol-related infusion syndrome in the peripartum period
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061574/
https://www.ncbi.nlm.nih.gov/pubmed/27738550
http://dx.doi.org/10.1055/s-0036-1593405
work_keys_str_mv AT eziefuleakwugoa propofolrelatedinfusionsyndromeintheperipartumperiod
AT elshatanoufysolafa propofolrelatedinfusionsyndromeintheperipartumperiod
AT thakurmili propofolrelatedinfusionsyndromeintheperipartumperiod
AT rochafredericog propofolrelatedinfusionsyndromeintheperipartumperiod